Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTIDEPRESSIVOS, TRANSTORNOS MENTAIS, DEPRESSÃO
ABNT
CERDEIRA, Rafaela Slaviero Pinheiro e HIRATA, Mario Hiroyuki. Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment. Brazilian Journal of Pharmaceutical Sciences, v. 61, p. 1-9 art. e24142, 2025Tradução . . Disponível em: https://dx.doi.org/10.1590/s2175-97902025e24142. Acesso em: 23 maio 2025.APA
Cerdeira, R. S. P., & Hirata, M. H. (2025). Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment. Brazilian Journal of Pharmaceutical Sciences, 61, 1-9 art. e24142. doi:10.1590/s2175-97902025e24142NLM
Cerdeira RSP, Hirata MH. Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2025 ; 61 1-9 art. e24142.[citado 2025 maio 23 ] Available from: https://dx.doi.org/10.1590/s2175-97902025e24142Vancouver
Cerdeira RSP, Hirata MH. Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2025 ; 61 1-9 art. e24142.[citado 2025 maio 23 ] Available from: https://dx.doi.org/10.1590/s2175-97902025e24142